Table 1

The plasma and brain parenchyma concentrations of 6-Cl-ddP, ddI, and nelfinavir after 6-Cl-ddP, nelfinavir, and GF120918 administrations (mean ± S.D.; n = 3)

Dose6-Cl in Plasma6-Cl in Brain ParenchymaddI in PlasmaddI in Brain ParenchymaNelf in PlasmaNelf in Brain Parenchyma
μg/ml μg/g μg/ml μg/g μg/ml μg/g
6-Cl14.7  ± 6.05.5  ± 2.311.6  ± 0.86.2  ± 0.2
(17.2  ± 3.6)(11.6  ± 4.6)(7.9  ± 1.8)(6.4  ± 1.7)
6-Cl + Nelf18.8  ± 10.47.3  ± 2.212.3  ± 1.25.3  ± 0.815.9  ± 4.40.2  ± 0.2
6-Cl +91822.6  ± 9.810.9  ± 0.813.9  ± 3.17.9  ± 0.21-a 1-b
Nelf12.5  ± 1.20.3  ± 0.2
Nelf +91812.3  ± 2.523.2  ± 2.61-b 1-d
6-Cl + Nelf +91825.4  ± 10.311.0  ± 4.520.2  ± 3.01-a 1-b 1-c 12.2  ± 0.31-a 1-b 1-c 14.4  ± 5.816.0  ± 4.91-b 1-d 1-e

Values in parenthesis are from Morgan et al. (1992).

  • 6-Cl, 6-Cl-ddP; Nelf, nelfinavir; 918, GF120918.

  • 1-a  Values are significantly different from 6-Cl.

  • 1-b  Values are significantly different from 6-Cl + Nelf.

  • 1-c  Values are significantly different from 6-Cl + 918.

  • 1-d  Values are significantly different from Nelf.

  • 1-e  Values are significantly different from Nelf + 918 (p < 0.05, Two-way analysis of variance and Tukey's post hoc test).